Clinical translation requires human CSF pharmacokinetic assays to prove BBB bypass, a rigorous dose-escalation Phase I trial to establish a safe human NOAEL for chronic dosing, and an RCT utilizing precise neurocognitive testing (e.g., MoCA) to confirm that murine transcriptomic shifts yield functional neuroprotection in humans
J Dermatol Sci 36:19 Shouman K, Benarroch EE (2021) Peripheral neuroimmune interactions: selected review and some clinical implications
Also, why leave the patient perhaps 2 weeks without their treatment when they need it
This precise delivery mechanism helps to prevent undesired dispersion, absorption, or hydrolysis by non-targeted organelles, thus enhancing the efficacy of the treatment (Fig
Chemical reactivity window determines prodrug efficiency toward glutathione transferase overexpressing cancer cells
It is supplied strictly as a laboratory research material for non-clinical investigations conducted under appropriate scientific protocols